Browse by specialty
In Vivo & In Vitro Nuclear Medicine
In 2025, 1 In Vivo & In Vitro Nuclear Medicine providers had general (non-research) payments reported to CMS. Half received less than $39.20 for the year, and nine in ten received less than $39.20.
1providers with payments in 2025
$39.20median total for the year
$39.20nine in ten received less than
$39.20average total for the year
Providers with the largest 2025 totals
Ordered by 2025 general-payment totals as reported to CMS. A large total is not evidence of wrongdoing; context is below the table.
| Provider | Location | 2025 general | All payments 2019-2025 including research |
|---|---|---|---|
| Raghuveer K Halkar | Atlanta, GA | $39.20 | $160.25 |
| Arnold Berkowitz | Murrieta, CA | $0.00 | $839.34 |
| Joel Ramos Ayala | San Juan, PR | $0.00 | $213.61 |
| Chaitanya Sk Chandarlapaty | Miami, FL | $0.00 | $25.01 |
| Adrian Alvarez De La Campa | Ponce, PR | $0.00 | $342.36 |
| Charles Arthur Barnett | Mather, CA | $0.00 | $68.86 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026).